Alan Burnett
Prosiectau fel Prif Ymchwiliwr
- Accuracy testing of the chromosomal aberration and gene mutation markers of the AML profiler (01.03.2011 - 31.07.2013)
- Acute myeloid leukaemia or high risk myelodysplastic syndrome multi-site randomised trial (27.02.2011 - 31.12.2011)
- Acute Myeoild Leukaemia Trial (AML 15) Trial Grant (01.07.2002 - 31.12.2009)
- AML 15 Trial Support Account (01.07.2002 - 31.07.2010)
- AML 16 A protocol for older patients with acute myeloid luekaemia and high risk myelodysplastic syndrome (01.12.2006 - 01.12.2011)
Prosiectau fel Cyd-Ymchwiliwr
- Role of OGG1 in the pathogenesis of acute myeloid leukaemia (01.04.2009 - 30.09.2011)
- Targets for treatment in AML: Discovery and translation (01.04.2010 - 19.09.2013)
- Targets for treatment in AML: Discovery and translation (20.09.2013 - 01.12.2015)
- Use of microarray to identify the mechanism of developmental disruption induced by over-expression of g-catenin in AML (01.02.2008 - 31.07.2009)
- Wales Cancer Trials Network (01.09.2004 - 31.08.2009)